Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation

American Journal of Hematology

Volumn 87, Issue 6, 2012, Pages 641-642

  Vannata, Barbara ^a   Laurenti, Luca ^a   Chiusolo, Patrizia ^a   Sorà, Federica ^a   Balducci, Mario ^a   Sabatelli, Mario ^a   Luigetti, Marco ^a   Giannotta, Claudia ^b   De Stefano, Valerio ^a   Leone, Giuseppe ^a   Sica, Simona ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; LENALIDOMIDE; M PROTEIN; PREDNISOLONE; VASCULOTROPIN;

ADULT; ANASARCA; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BONE RADIOGRAPHY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG USE; DYSPNEA; ELECTROMYOGRAPHY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; HYPOTHYROIDISM; IMMUNOGLOBULIN A GAMMA MONOCLONAL GAMMOPATHY; LETTER; LIMB PAIN; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE CYCLE TREATMENT; MUSCLE WEAKNESS; NORMOCHROMIC NORMOCYTIC ANEMIA; PHYSICAL EXAMINATION; POEMS SYNDROME; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUADRIPLEGIA; RECURRENT DISEASE; RELAPSE; SCLERODERMA; SPLENOMEGALY; TREATMENT OUTCOME; WALKING DIFFICULTY; WEIGHT REDUCTION;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DEXAMETHASONE; HUMANS; HUMERUS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; OSTEOSCLEROSIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POEMS SYNDROME; PREDNISOLONE; RECURRENCE; SALVAGE THERAPY; THALIDOMIDE; TRANSPLANTATION, AUTOLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 84861345435     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23195     Document Type: Letter

References (30)

1. Bardwick PA, Zvaifler NJ, Gill GN, et al. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: The POEMS syndrome. Report on two cases and a review of the literature. Medicine 1980; 59: 311-322.
2. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome: A study of 102 cases in Japan. Neurology 1984; 34: 712-720.
3. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: Definitions and long-term outcome. Blood 2003; 101: 2496-2506.
4. Dispenzieri A. POEMS syndrome: 2011 update on diagnosis, risk-stratification and management. Am J Haematol 2011; 86: 591-601.
5. Allam JS, Kennedy CC, Aksamit TR, Dispenzieri A. Pulmonary manifestation in patients with POEMS syndrome. A retrospective review of 137 patients. Chest 2008: 133: 969-974.
6. Laurenti L, De Matteis S, Sabatelli M, et al. Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome. Leuk Res 2008; 32: 1309-1312.
7. Gupta S, Rana V, Chandra D, et al. Autologous peripheral stem cell transplant for POEMS syndrome: A case report. Hematology 2006; 11: 361-363.
8. Kuwabara S, Misawa S, Kanai K, et al. Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology 2006; 66: 105-107.
9. Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 2004; 104: 3400-3407.
10. Jaccard A, Royer B, Bordessoule D, et al. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood 2002; 99: 3057-3059.
11. Rovira M, Carreras E, Bladé J, et al. Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation. Br J Haematol 2001; 115: 373-375.
12. Hogan WJ, Lacy MQ, Wiseman GA, et al. Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation. Bone Marrow Transpl 2001; 28: 305-309.
13. Sabatelli M, Luigetti M, Laurenti L, et al. Neurologic improvement after peripheral blood stem cell transplantation in poems. Neurology 2009; 73: 1165; author reply 1165-1166.
14. Tang X, Shi X, Sun A, et al. Successful bortezomib-based treatment in POEMS syndrome. Eur J Haematol 2009; 83: 609-610.
15. Kaygusuz I, Tezcan H, Cetiner M, et al. Bortezomib: A new therapeutic option for POEMS syndrome. Eur J Haematol 2010; 84: 175-177.
16. Straume O, Bergheim J, Ernst T. Bevacizumab therapy for POEMS syndrome. Blood 2006; 107: 4972-4973: author reply 4973-4974.
17. Samaras P, Bauer S, Stenner-Liewen R, et al. Treatment of POEMS syndrome with bevacizumab. Haematologica 2007; 92: 1438-1439.
18. Ohwada C, Nakaseko C, Sakai S, et al Successful combination treatment with bevacizumab, thalidomide and autologous PBSCT for severe POEMS syndrome. Bone Marrow Transpl 2009; 43: 739-740.
19. Dispenzieri A, Klein CJ, Mauermann ML. Lenalidomide therapy in a patient with POEMS syndrome. Blood 2007; 110: 1075-1076.
20. Jaccard A, Abraham J, Recher C, et al. Lenalidomide therapy in nine patients with POEMS syndrome. ASH 2009-Abs 3872.
21. Tomas JF, Giraldo P, Lecumberri R, Nistal S. POEMS syndrome with severe neurological damage clinically recovered with Lenalidomide. Haematologica 2012; 97: 320-322.
22. Nozza A, Terenghi F, Mazza R, et al. Efficacy of lenalidomide in patients with POEMS syndrome: A pilot study. Haematologica 2011; 96 ( Suppl 3):abstr C010.
23. Soubrier M, Dubost JJ, Serre AF, et al. Growth factors in POEMS syndrome: Evidence for a marked increase in circulating VEGF. Arthrit Rheum 1997; 40: 786-787.
24. Dimopoulos MA, Palumbo A, Beksaç M, et al. Optimizing the use of Lenalidomide in relapsed or refractoty multiple myeloma: Consensus statement. Leukemia 2011; 25: 749-760.
25. Gertz MA, Merlini G. Definition of organ involvement and response to treatment in AL amyloidosis: An updated consensus opinion [abstract]. Amyloid 2010; 17( s1): 48.
26. Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, April 18-22, 2004. Am J Hematol 2005; 79: 319-328.
27. Merkies IS, Schmitz PI, van der Meché FG, Samijn JP, van Doorn PA; Inflammatory Neuropathy Cause and Treatment (INCAT) group. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2002; 72: 596-601.
28. Palumbo A, Gay F, Falco P, et al. Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients. J Clin Oncol 2010; 28: 800-807.
29. Mc Carthy PL, Owzar K, Anderson KC et al. Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous stem cell transplant (ASCT) for multiple myeloma (MM): CALGB 100104. J Clin Oncol 28:15s, 2010 (suppl; abstr 8017).
30. Attal M, Cristini C, Marit G, et al. Lenalidomide maintenance after transplantation in Multiple Myeloma. J Clin Oncol 28:15s, 2010 (suppl; abstr 8018).